A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma
Clinical trial NCT05577416 · COMPLETED
Trial details
- NCT number
- NCT05577416
- Sponsor
- Melbourne Health
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-11
- Primary completion
- 2025-03-26
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.